CPG3 Pediatric Obesity - Assessment, Treatment and Prevention: An Endocrine Society Clinical Practice Guideline

Program: Clinical Practice Guidelines
Clinical Session
Sunday, April 3, 2016: 8:30 AM-9:30 AM
BR West (BCEC)
Moderator:
Ilene Fennoy, MD, MPH, Columbia University Medical Center, New York, NY
Chair:
Dennis M Styne, University of California-Davis, Sacramento, CA
Task Force Participants:
Silva A Arslanian, MD, Children's Hosp of Pittsburgh of UPMC, Pittsburgh, PA , Ellen Lancon Connor, MD, University of Wisconsin, Madison, WI , Janet H Silverstein, MD, Univeristy of Florida College of Medicine, Gainesville, FL and Jack Adam Yanovski, MD, PhD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD

Disclosures:
DMS: Investigator, Zafgen Inc. JAY: Principal Investigator, Zafgen, Inc.. Nothing to Disclose: IF, SAA, ELC, JHS Disclosure Not Provided: IF

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire